Lotus Response to the Coronavirus (COVID-19)
At Lotus Clinical Research, the safety of our patients, employees and customers remains our highest priority.
In the coming weeks and months, in accordance with public health department…
At Lotus Clinical Research, the safety of our patients, employees and customers remains our highest priority.
In the coming weeks and months, in accordance with public health department…
September is Pain Awareness Month! Lotus Clinical Research’s mission is to reduce prescription drug misuse and abuse by inventing and validating scientific technologies that improve analgesic study design and conduct.
When it comes to subject dropouts, an ounce of prevention is worth a pound of cure. Lotus Clinical Research has created a subject and investigator education series that can reduce subject dropout rates.
The prevailing soft tissue acute pain surgical models (hemorrhoidectomy, herniorrhaphy, hysterectomy, laparoscopic cholecystectomy, colon surgery) are slow to recruit and present financial and logistical challenges
Bunionectomy as an Analgesic Model In analgesic clinical trials, selecting the type of model to use can be challenging as each has their own pros and cons. As an analgesic model, Bunionectomy has excellent assay sensitivity. In the paper linked below our Chief Scientific Officer, Dr. Neil Singla, discusses the clinical and experimental characteristics of four acute surgical … Read more
Measuring Respiratory Depression in Analgesic Studies Demonstrating that a novel analgesic provides pain relief but does not cause respiratory depression can be a significant challenge. Our Chief Scientific Officer, Dr. Neil Singla, has extensive expertise in clinical trials focusing on the evaluation of respiratory endpoints in analgesic studies. In a Phase 2b study in acute pain, … Read more
In analgesic clinical trials, managing placebo response can make the difference between a successful study and a false negative outcome.